1.78
price down icon2.20%   -0.04
after-market Dopo l'orario di chiusura: 1.82 0.04 +2.25%
loading
Precedente Chiudi:
$1.82
Aprire:
$1.82
Volume 24 ore:
167.75K
Relative Volume:
0.51
Capitalizzazione di mercato:
$1.06M
Reddito:
-
Utile/perdita netta:
$-8.26M
Rapporto P/E:
-0.0332
EPS:
-53.609
Flusso di cassa netto:
$-12.17M
1 W Prestazione:
+21.92%
1M Prestazione:
-59.23%
6M Prestazione:
-84.52%
1 anno Prestazione:
-98.13%
Intervallo 1D:
Value
$1.69
$1.93
Intervallo di 1 settimana:
Value
$1.42
$2.11
Portata 52W:
Value
$1.10
$106.04

Gri Bio Inc Stock (GRI) Company Profile

Name
Nome
Gri Bio Inc
Name
Telefono
(619) 400-1171
Name
Indirizzo
2223 AVENIDA DE LA PLAYA, LA JOLLA
Name
Dipendente
4
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
GRI's Discussions on Twitter

Confronta GRI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GRI
Gri Bio Inc
1.78 1.06M 0 -8.26M -12.17M -53.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Gri Bio Inc Stock (GRI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-09 Iniziato H.C. Wainwright Buy

Gri Bio Inc Borsa (GRI) Ultime notizie

pulisher
Apr 24, 2025

GRI Bio Inc (GRI) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 24, 2025
pulisher
Apr 17, 2025

FY2025 Earnings Forecast for GRI Bio Issued By HC Wainwright - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

GRI Bio appoints Withum as new accounting firm By Investing.com - Investing.com Canada

Apr 16, 2025
pulisher
Apr 16, 2025

GRI Bio Announces Abstract Selected for Poster Discussion - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

Major Scientific Breakthrough: GRI Bio's Novel Pulmonary Fibrosis Treatment Shows Promise - Stock Titan

Apr 16, 2025
pulisher
Apr 16, 2025

GRI Bio appoints Withum as new accounting firm - Investing.com Australia

Apr 16, 2025
pulisher
Apr 15, 2025

GRI Bio (NASDAQ:GRI) Given Buy Rating at HC Wainwright - Defense World

Apr 15, 2025
pulisher
Apr 15, 2025

H.C. Wainwright maintains Buy on GRI Bio stock, $10 target - Investing.com Australia

Apr 15, 2025
pulisher
Apr 14, 2025

H.C. Wainwright maintains Buy on GRI Bio stock, $10 target By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 09, 2025

GRI stock touches 52-week low at $1.2 amid market fluctuations - Investing.com

Apr 09, 2025
pulisher
Apr 04, 2025

GRI Bio regains compliance with Nasdaq’s minimum bid price rule - MSN

Apr 04, 2025
pulisher
Apr 03, 2025

GRI Bio Announces Closing of $5.0 Million Public Offering - The Manila Times

Apr 03, 2025
pulisher
Apr 02, 2025

GRI Stock Down on Public Offering Despite Encouraging IPF Study Data - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Gri Bio Announces Closing Of $5.0 Million Public Offering - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

GRI Bio Raises $5M, Eyes $18.3M Total Potential for Breakthrough Autoimmune Treatment - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

GRI Stock Down On Public Offering Despite Encouraging IPF Study Data - Barchart.com

Apr 02, 2025
pulisher
Apr 02, 2025

GRI Bio Shares Rebound In After-Hours Trading - Stocks Telegraph

Apr 02, 2025
pulisher
Apr 01, 2025

GRI Bio (GRI) Reports Positive Interim Safety Results for IPF Tr - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

Street can a-GRI on phase IIb safety win in IPF with tazarotene - BioWorld MedTech

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Announces $5 Million Public Offering Amid Market Decline - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Prices up to $13 Million Equity Offering - marketscreener.com

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio announces $5 million public offering - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio announces $5 million public offering By Investing.com - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Announces Pricing of $5.0 Million Public Offering - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Secures $5M Funding Deal: Warrants Could Add $13.3M More - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?GRI Bio (NASDAQ:GRI) - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio’s IPF drug shows promise in early trial By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis ("IPF - The Manila Times

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio reports interim 2-week safety results from Phase 2a study of GRI-0621 - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio’s IPF drug shows promise in early trial - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Gri Bio IncIDMC Recommends Continuation Of Study With No Safety Concerns - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Reports Encouraging Interim 2-Week Safety Results - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Clinical Trial Breakthrough: GRI-0621 Clears Key Safety Milestone for IPF Treatment - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

GRI Bio secures global patents for NKT cell modulators By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

GRI Bio secures global patents for NKT cell modulators - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

GRI Bio announces the granting of two global patents for Europe, Japan - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Global Patent Victory: GRI Bio's Breakthrough NKT Cell Treatment for Autoimmune Disease Gets Dual Approval - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Vallon Pharmaceuticals stock plunges to 52-week low of $4.95 By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Vallon Pharmaceuticals stock plunges to 52-week low of $4.95 - Investing.com India

Mar 28, 2025
pulisher
Mar 20, 2025

GRI Bio (GRI) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

GRI Bio Participates in a Virtual Investor CEO Connect Segment - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

GRI Bio's Breakthrough IPF Drug Shows Promise, Key Data Coming Next Quarter - StockTitan

Mar 18, 2025

Gri Bio Inc Azioni (GRI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Capitalizzazione:     |  Volume (24 ore):